SAN ANTONIO--(BUSINESS WIRE)--Azaya Therapeutics Inc., a clinical-stage oncology company developing more effective cancer treatments through its nanotechnology platform, announced an exclusive license ...
Azaya Therapeutics Inc. expects to close this week on a $5 million bridge funding round . Azaya Therapeutics Inc. expects to close this week on a $5 million bridge funding round that the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results